• Skip to primary navigation
  • Skip to main content

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • iPSC Quality Assessment Rounds
    • iPSC Quality Assessment Round 2022/2023
      • iPSC Quality Assessment Round 2022 – Document Page
  • Directories
  • Clinical Database
  • Portal Login

Main Content

Welcome to GAiT

The Global Alliance for iPSC Therapies

Portal Log in Learn more

About Us

GAiT is an international resource to facilitate the therapeutic use of immunogenetically matched, clinical-grade new types of stem cells (iPSCs) for the benefit of patients globally.  GAiT’s vision is that patients globally will have equity of access to this new generation of iPSC-derived cell therapy products.

our mission

GAiT’s mission is to enable the global human community the opportunity to benefit from the new generation of cell therapies by facilitating the development of, and access to, clinical-grade and haplotyped induced pluripotent stem cells for the manufacture of cell therapy products.

Our Objectives

  • Achieve consensus on donor selection and screening criteria and consent standards.
  • Achieve global consensus on manufacturing and quality parameters and standards required to consider an iPSC line to be of clinical grade and develop an external quality assurance scheme to facilitate the development of comparability between centres.
  • Gain agreement with regulators in various jurisdictions as to the acceptability of the quality standards proposed.
  • Develop a database of clinical grade iPSC lines.

News & Events

The latest from GAiT

Find us on Twitter
IPSCtherapies avatar; GAiT @IPSCtherapies ·
15 Dec 1603361474143035396

GAiT joins CCRM on their latest podcast to discuss the clinical potential of induced Pluripotent Stem Cells

Image for twitter card

‎Commercializing Living Therapies with CCRM: Unlocking the potential of induced pluripotent stem cells on Apple Podcasts

‎Show Commercializing Living Therapies with CCRM, Ep Unlocking the potential of induced pluripotent stem cells - Dec 14, 2022

podcasts.apple.com

Reply on Twitter 1603361474143035396 Retweet on Twitter 1603361474143035396 0 Like on Twitter 1603361474143035396 0 Twitter 1603361474143035396
Retweet on Twitter GAiT Retweeted
nyscf avatar; New York Stem Cell Foundation Research Institute @nyscf ·
9 Sep 1568178462216671233

With a very heavy heart, we announce the passing of our CEO and co-founder, Susan Solomon, following a long battle with ovarian cancer. We owe all that NYSCF has accomplished to Susan, and no words can express our gratitude and awe for her catalytic impact on stem cell research.

Image for the Tweet beginning: With a very heavy heart, Twitter feed image.
Reply on Twitter 1568178462216671233 Retweet on Twitter 1568178462216671233 52 Like on Twitter 1568178462216671233 260 Twitter 1568178462216671233
Retweet on Twitter GAiT Retweeted
RySciComms avatar; Ry Leahy @RySciComms ·
31 Aug 1564923762658738176

Great panel on regulatory futures for CGT from various perspectives - Niloofar Davoodi, @TakedaPharma, Ian Rees, @MHRAgovuk, Michael von Forstner, @biogen and led by Jacqueline Barry, @CGTCatapult

#advancedtherapieseurope #ate2022 #ate22 #celltherapy #regulatory

Image for the Tweet beginning: Great panel on regulatory futures Twitter feed image.
Reply on Twitter 1564923762658738176 Retweet on Twitter 1564923762658738176 2 Like on Twitter 1564923762658738176 1 Twitter 1564923762658738176
Retweet on Twitter GAiT Retweeted
paras_biotech avatar; Paras Sharma @paras_biotech ·
25 Aug 1562949481657614339

Companies developing iPSC-based cell therapies

Image for the Tweet beginning: Companies developing iPSC-based cell therapies Twitter feed image.
Reply on Twitter 1562949481657614339 Retweet on Twitter 1562949481657614339 55 Like on Twitter 1562949481657614339 306 Twitter 1562949481657614339
Retweet on Twitter GAiT Retweeted
CGT_Insights avatar; Cell & Gene Therapy @CGT_Insights ·
22 Aug 1561689642554085377

Characterization of advanced therapies: leveraging advanced #analytics to avoid #FDA holds

Find out the key #assay types needed for successful characterization of #cellandgenetherapy

Read the FastFacts poster, or watch the video, here: http://bit.ly/3AxQmMz

#celltherapy

Image for the Tweet beginning: Characterization of advanced therapies: leveraging Twitter feed image.
Reply on Twitter 1561689642554085377 Retweet on Twitter 1561689642554085377 5 Like on Twitter 1561689642554085377 5 Twitter 1561689642554085377
IPSCtherapies avatar; GAiT @IPSCtherapies ·
22 Aug 1561763439541981184

https://advancedtherapiesweek.phacilitate.com/

Image for the Tweet beginning:  Twitter feed image.
Reply on Twitter 1561763439541981184 Retweet on Twitter 1561763439541981184 0 Like on Twitter 1561763439541981184 1 Twitter 1561763439541981184
Load More...

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2023 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login